Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs. | Int J Mol Sci | 2023 | 38003248 | PubTator, text mining | PubMed |
| Topoisomerase 1 Activity Is Reduced in Response to Thermal Stress in Fruit Flies and in Human HeLa Cells. | Biosensors (Basel) | 2023 | 37998125 | PubTator, text mining | PubMed |
| Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. | Cancer Res | 2023 | 37987734 | PubTator, text mining | PubMed |
| Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy. | Antibodies (Basel) | 2023 | 37987250 | PubTator, text mining | PubMed |
| A sequence-based evolutionary distance method for Phylogenetic analysis of highly divergent proteins. | Sci Rep | 2023 | 37985846 | PubTator, text mining | PubMed |
| Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. | Clin Respir J | 2023 | 37985446 | PubTator, text mining | PubMed |
| The TDRD3-USP9X complex and MIB1 regulate TOP3B homeostasis and prevent deleterious TOP3B cleavage complexes. | Nat Commun | 2023 | 37980342 | PubTator, text mining | PubMed |
| Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023). | World J Gastroenterol | 2023 | 37970478 | PubTator, text mining | PubMed |
| The nucleolar protein GNL3 prevents resection of stalled replication forks. | EMBO Rep | 2023 | 37965896 | PubTator, text mining | PubMed |
| Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder. | Front Cell Neurosci | 2023 | 37964795 | PubTator, text mining | PubMed |
| A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics. | Nat Commun | 2023 | 37957169 | PubTator, text mining | PubMed |
| Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity. | RSC Adv | 2023 | 37954422 | PubTator, text mining | PubMed |
| TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription. | Nat Commun | 2023 | 37945566 | PubTator, text mining | PubMed |
| The proofreading exonuclease of leading-strand DNA polymerase epsilon prevents replication fork collapse at broken template strands. | Nucleic Acids Res | 2023 | 37944988 | PubTator, text mining | PubMed |
| XPF interacts with TOP2B for R-loop processing and DNA looping on actively transcribed genes. | Sci Adv | 2023 | 37939182 | PubTator, text mining | PubMed |
| Targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938771 | PubTator, text mining | PubMed |
| Differences in Leukocyte Transcriptomes of Morbidly Obese Patients With High Output Heart Failure: A Pilot Study. | Int J Heart Fail | 2023 | 37937202 | PubTator, text mining | PubMed |
| An adaptively multi-correlations aggregation network for skeleton-based motion recognition. | Sci Rep | 2023 | 37932348 | PubTator, text mining | PubMed |
| Rational therapeutic targets with biomolecular liquid-liquid phase separation regulating synergy: A pan-cancer analysis. | PLoS One | 2023 | 37917664 | PubTator, text mining | PubMed |
| Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response. | Eur J Cancer | 2023 | 37913680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=21